ArticleInternational journal of molecular sciences2024

Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts.

Daisuke Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.